Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
Michelle T Lee, Dhruv Mahtta, David J Ramsey...
https://pubmed.ncbi.nlm.nih.gov/33881448Actively Recruiting
Led by Queen Mary University of London · Updated on 2025-09-08
6000
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are investigating how Coronary Artery Disease (CAD), a condition where the heart's arteries become blocked or narrowed, starts and progresses, especially in women. The study aims to understand the role of inflammation and sex hormones like oestrogen and testosterone in CAD, which may explain why women have different risks and outcomes than men. This observational study focuses on patients with chest pain attending Barts Heart Centre and seeks to address gaps in knowledge about sex differences in CAD. The study involves collecting blood samples to measure sex hormone levels and various inflammatory markers from patients admitted with chest pain. Patients will also complete questionnaires about their hormone status and medical history. For those previously treated at the centre, questionnaires will be conducted by telephone. Blood samples will be analyzed at a research institute for detailed inflammatory profiles. Any significant abnormal results will be communicated to the patient's care team with appropriate follow-up. Participants' medical data and questionnaire responses will be securely stored and combined with routine clinical information to explore links between hormones, inflammation, and CAD outcomes. Follow-up will occur at 30 days, 1 year, and 5 years to track mortality, hospital readmissions, and major cardiac events. This comprehensive approach aims to improve understanding of CAD progression and treatment in both women and men.
CONDITIONS
Barts Sex-CAD Database - Sex Hormones and Inflammatory Status in Coronary Artery Disease
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during hospital admission
Duration - During hospital admission and shortly after discharge
Participants have blood tests collected to assess sex hormone levels and inflammatory markers. A questionnaire is completed to gather relevant medical and menstrual history affecting hormone status.
1 blood sample collection visit (in-person) and 1 questionnaire visit (in-person or telephone)
Duration - Up to 5 years
Participants' health outcomes such as mortality, readmission, and cardiovascular events are monitored through electronic patient records at 30 days, 1 year, and 5 years.
No additional visits; monitoring occurs via electronic records
Total: 1 location
1
Barts Health NHS Trust
London, United Kingdom
Actively Recruiting
K
Krishnaraj Rathod, MBBS PhD
A
Amrita Ahluwalia, BSc PhD
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Michelle T Lee, Dhruv Mahtta, David J Ramsey...
https://pubmed.ncbi.nlm.nih.gov/33881448Asad Shabbir, Krishnaraj Sinhji Rathod, Rayomand Syrus Khambata...
https://pubmed.ncbi.nlm.nih.gov/33035428Krishnaraj S Rathod, Daniel A Jones, Ajay K Jain...
https://pubmed.ncbi.nlm.nih.gov/34849299